KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Acquisitions (2019 - 2025)

Astrana Health's Acquisitions history spans 9 years, with the latest figure at $548.6 million for Q3 2025.

  • For Q3 2025, Acquisitions rose 60246.86% year-over-year to $548.6 million; the TTM value through Sep 2025 reached $579.3 million, up 393.74%, while the annual FY2024 figure was $146.3 million, 2146.01% up from the prior year.
  • Acquisitions for Q3 2025 was $548.6 million at Astrana Health, up from $30.8 million in the prior quarter.
  • Across five years, Acquisitions topped out at $548.6 million in Q3 2025 and bottomed at -$350000.0 in Q2 2023.
  • The 5-year median for Acquisitions is $2.5 million (2021), against an average of $48.0 million.
  • The largest YoY upside for Acquisitions was 107280.0% in 2022 against a maximum downside of 220.51% in 2022.
  • A 5-year view of Acquisitions shows it stood at $10000.0 in 2021, then soared by 107280.0% to $10.7 million in 2022, then tumbled by 82.88% to $1.8 million in 2023, then surged by 1573.88% to $30.8 million in 2024, then surged by 1682.98% to $548.6 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Acquisitions are $548.6 million (Q3 2025), $30.8 million (Q4 2024), and $909000.0 (Q3 2024).